cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors-Reference-Cited by-同舟云学术

cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors

Published:2020-06-23 Issue: Volume: Page:
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathol

Author:

Ellison David W.¹^ORCID,Aldape Kenneth D.²,Capper David³,Fouladi Maryam⁴,Gilbert Mark R.⁵,Gilbertson Richard J.⁶,Hawkins Cynthia⁷,Merchant Thomas E.⁸,Pajtler Kristian⁹,Venneti Sriram¹⁰^ORCID,Louis David N.¹¹^ORCID

Affiliation:

1. Department of Pathology St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis TN38105USA

2. Center for Cancer Research Laboratory of Pathology National Cancer Institute Bethesda MDUSA

3. Department of Neuropathology Charité Universitätsmedizin Berlin Germany

4. Brain Tumor Center Division of Oncology Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati OHUSA

5. Neuro‐Oncology Branch National Cancer InstituteNational Institutes of Health Bethesda MDUSA

6. Department of Oncology Cambridge Cancer Centre Robinson Way CambridgeCB2 0REUK

7. Division of Pathology The Hospital for Sick Children Toronto Ontario Canada

8. Department of Radiation Oncology St. Jude Children's Research Hospital 262 Danny Thomas PlaceMS 210 Memphis TN38105USA

9. Division of Pediatric Neurooncology German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany

10. Department of Pathology University of Michigan Ann Arbor MI48109USA

11. Department of Pathology Massachusetts General Hospital Harvard Medical School Boston MA02114USA

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bpa.12866

Reference23 articles.

1. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features

2. DNA methylation-based classification of central nervous system tumours

3. Heterogeneity within the PF-EPN-B ependymoma subgroup

4. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

5. MYCN amplification drives an aggressive form of spinal ependymoma

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas;Acta Neuropathologica;2024-01-24

2. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis;Pathology International;2024-01-15

3. Morphology‐based molecular classification of spinal cord ependymomas using deep neural networks;Brain Pathology;2024-01-11

4. Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next;Brain Tumor Pathology;2023-12-19

5. Adolescents and Young Adults With Cancer: CNS Tumors;Journal of Clinical Oncology;2023-12-08